Literature DB >> 3695294

[Determinants of plasma digoxin and digitoxin concentrations in elderly patients. A multivariate analysis].

W Koenig1, N Rietbrock, B G Woodcock, W Lehmacher.   

Abstract

In 1063 patients (greater than or equal to 60 years, 531 men, 532 women) the plasma concentration during digitalis maintenance therapy (metildigoxin, n = 356, beta-acetyldigoxin, n = 359, and digitoxin, n = 348) was determined and related to sex, age, body weight, serum potassium, renal function and the prescribed daily maintenance dose. Classification of treatment groups according to renal function (Crea less than or equal to 1.3 mg/dl parallel greater than 1.3 mg/dl) did not show any difference of the mean maintenance doses. In multiple linear regression analyses only a weak relationship between plasma digitalis concentration and the studied variables was found, which could be equally attributed to dose, creatinine and serum potassium in the digoxin derivative groups, whereas for digitoxin only body weight had a significant effect on the plasma concentration. During a maintenance dose of 0.07 or 0.1 mg/die which was given to 87% of patients in the digitoxin group, 70% were found to have plasma levels within the therapeutic range.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3695294     DOI: 10.1007/bf01736113

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  12 in total

1.  Prediction of creatinine clearance from serum creatinine.

Authors:  D W Cockcroft; M H Gault
Journal:  Nephron       Date:  1976       Impact factor: 2.847

2.  [Plasma-digoxin concentration in patients at time of hospital admission (author's transl)].

Authors:  J Lichey; R Schröder; N Rietbrock
Journal:  Dtsch Med Wochenschr       Date:  1977-07-22       Impact factor: 0.628

3.  [Prospective evaluation of glycoside therapy of patients on admission to hospital (author's transl)].

Authors:  G Bodem; H R Ochs; R Meyer; M P Baur
Journal:  Z Kardiol       Date:  1979-01

4.  Use of digitalis in general practice. Liverpool Therapeutics Group.

Authors: 
Journal:  Br Med J       Date:  1978-09-02

5.  Epidemiology of plasma digoxin concentrations in three patient populations.

Authors:  G D Johnson; D G McDevitt
Journal:  Ir J Med Sci       Date:  1980-02       Impact factor: 1.568

6.  Clinical implications of serum digoxin concentrations.

Authors:  H R Ochs; D J Greenblatt; J S Harmatz; G Bodem; H J Dengler
Journal:  Klin Wochenschr       Date:  1981-05-15

7.  Serum digoxin concentrations and subjective manifestations of toxicity.

Authors:  H R Ochs; D J Greenblatt; J S Harmatz; G Bodem
Journal:  Pharmacology       Date:  1980       Impact factor: 2.547

8.  [Digitalis therapy: prescription frequency, serum concentrations and withdrawal trials].

Authors:  M Middeke; W Meister; C Krüger; B Krahl; H Holzgreve
Journal:  Klin Wochenschr       Date:  1985-08-16

9.  [Pharmacokinetics of digitoxin in chronic renal failure (author's transl)].

Authors:  U Peters; B Grabensee; T U Hausamen; W P Fritsch; F Grosse-Brockhoff
Journal:  Dtsch Med Wochenschr       Date:  1977-01-28       Impact factor: 0.628

10.  [Epidemiology of digitalis medication. Results of the Munich blood-pressure study].

Authors:  W Koenig; U Keil; J Stieber; A Döring; S J Pöppl; W Mraz
Journal:  Dtsch Med Wochenschr       Date:  1984-03-16       Impact factor: 0.628

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.